Budesonide
NDC 53746-778, Budesonide, capsule, delayed release, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 53746-778
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206200
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53746-778 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE3 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53746-778-10 | 53746077810 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (53746-778-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/10336e42-0e9d-45c4-80bc-5149d5ec9e1cNADAC price for package 53746077810
GET /v1/drugs/nadac/53746077810
Use it
Look up 53746-778 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53746-778 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53746-778. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.